Novartis holds itself to high standards of sustainability and ethical business conduct. Independent third-party ratings periodically assess us against selected environmental, social and governance (ESG) criteria.

Industry-leading performance across priority ESG ratings

RatingScore1Position / Status
Access to Medicine Index (ATMI)3.874th (in the leadership group for 10 years)
CDP Climate ChangeADouble A List status
CDP Water SecurityA
ISS ESGBLeader status
MSCIAALeader status
Sustainalytics*15.8Low Risk category

For more information on our awards and recognition, please click here.

Last update: April 2024

1. Scales: ATMI: 1 to 5; CDP: D- to A; ISS ESG: D- to A+ ; MSCI: CCC to AAA; Sustainalytics ESG Risk Rating: 0 (Negligible risk) to 40+ (Severe risk)

* Copyright © 2023 Morningstar Sustainalytics. All rights reserved. This publication contains information developed by Sustainalytics ( Such information and data are proprietary of Sustainalytics and/or its third-party suppliers (Third Party Data) and are provided for informational purposes only. They do not constitute an endorsement of any product or project, nor an investment advice and are not warranted to be complete, timely, accurate or suitable for a particular purpose. Their use is subject to conditions available at